作者
Manni Rohilla, Seema Bansal, Anjali Garg, Sachin Dhiman, Sanchit Dhankhar, Monika Saini, Samrat Chauhan, Nawal Alsubaie, Gaber El-Saber Batiha, Nisreen Khalid Aref Albezrah, Thakur Gurjeet Singh
发表日期
2023/12/31
来源
Biomedicine & Pharmacotherapy
卷号
169
页码范围
115881
出版商
Elsevier Masson
简介
Diabetic retinopathy (DR) is a form of retinal microangiopathy that occurs as a result of long-term Diabetes mellitus (DM). Patients with Diabetes mellitus typically suffer from DR as a progression of the disease that may be due to initiation and dysregulation of pathways like the polyol, hexosamine, the AGE/RAGE, and the PKC pathway, which all have negative impacts on eye health and vision. In this review, various databases, including PubMed, Google Scholar, Web of Science, and Science Direct, were scoured for data relevant to the aforementioned title. The three most common therapies for DR today are retinal photocoagulation, anti-vascular endothelial growth factor (VEGF) therapy, and vitrectomy, however, there are a number of drawbacks and limits to these methods. So, it is of critical importance and profound interest to discover treatments that may successfully address the pathogenesis of DR. Curcumin and …
引用总数